Skip to content

Straumann® BLC and TLC Implants SLActive Roxolid BL (REF 035.9206S)Recalls & reported problems

Institut Straumann AG · BLC Implant, Ø 3.75mm RB, SLActive® 6mm, Roxolid® · Class 2 · Implant

All models of Straumann BLC and TLC Implants (153)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Quick summary

This Straumann BLC implant is a root-form dental implant placed in the jawbone to hold a replacement tooth. Its 154 reports mostly describe the implant failing to fuse with the jawbone or losing that bond, and some mention pain or infection. The reports include no deaths and 154 injuries. No recalls name this device. Reports rose from 41 in the year before to 106 in the latest year.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
166
Deaths reported
0
Injuries reported
166
Recalls naming it
0

Summary

The FDA's MAUDE database contains 166 adverse event reports that list this exact device (DI 07630031764270), received between Apr 12, 2024 and Sep 28, 2026 — classified as 166 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (134 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 2 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 5 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 2 reportsDec 2024: 4 reportsJan 2025: 3 reportsFeb 2025: 2 reportsMar 2025: 1 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 12 reportsJul 2025: 2 reportsAug 2025: 8 reportsSep 2025: 4 reportsOct 2025: 2 reportsNov 2025: 13 reportsDec 2025: 6 reportsJan 2026: 7 reportsFeb 2026: 8 reportsMar 2026: 18 reportsApr 2026: 15 reportsMay 2026: 7 reportsJun 2026: 8 reportsJul 2026: 16 reportsAug 2026: 9 reportsSep 2026: 11 reportsOct 2026: 0 reports20242025202618
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate134
  • Loss of Osseointegration19
  • Adverse Event Without Identified Device or Use Problem12
  • Difficult to Insert1

Patient problems

  • No Clinical Signs, Symptoms or Conditions81
  • Fibrosis71
  • Pain27
  • Unspecified Infection16
  • Inflammation8
  • Abscess5
  • Hemorrhage/Blood Loss/Bleeding5
  • Swelling/ Edema5

Recent adverse event reports

The 25 most recent of 166 reports, in the reporter's own words as published by the FDA.

  • InjurySep 28, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50920157 ↗
  • InjurySep 28, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50919897 ↗
  • InjurySep 28, 2026Adverse Event Without Identified Device or Use Problem

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50919805 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50919662 ↗
  • InjurySep 28, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50918582 ↗
  • InjurySep 28, 2026Adverse Event Without Identified Device or Use Problem

    The clinician reports that the day the implant was placed in ADA 4, failure occurred upon insertion. Details of surgery: Primary stability not achieved and Ridge augmentation. Patient presented with bone type III and inadequate bone quality/quantity. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50918349 ↗
  • InjurySep 18, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in the patient's mouth. On 2026-08-17, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50826357 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50720390 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50720389 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50720346 ↗
  • InjurySep 7, 2026Adverse Event Without Identified Device or Use Problem

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50654548 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    Patient problems: Pain; Unspecified Infection

    MAUDE report 50415745 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50415410 ↗
  • InjuryAug 24, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50414429 ↗
  • InjuryAug 14, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 44. On (b)(6) 2026, loss of osseointegration was verified. Patient presented with bone type III and inadequate bone quality/quantity. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50259385 ↗
  • InjuryAug 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50258905 ↗
  • InjuryAug 14, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted 2025(b)(6) in the patient's mouth. On 2026(b)(6), non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50258895 ↗
  • InjuryAug 7, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in ADA 18. Details of surgery: Implant surface not completely covered with bone. On (b)(6) 2026, non-osseointegration was verified. Patient presented with bone type III and inadequate bone quality/quantity. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50179505 ↗
  • InjuryAug 3, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50121010 ↗
  • InjuryAug 3, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in ADA 14. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50118448 ↗
  • InjuryJul 31, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 47. Details of surgery: Primary stability not achieved. On (b)(6) 2026, non-osseointegration was verified. Patient presented with inadequate bone quality/quantity. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50102783 ↗
  • InjuryJul 30, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in FDI 35. Details of surgery: Implant surface not completely covered with bone. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50088941 ↗
  • InjuryJul 30, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted 2026(b)(6) in FDI 26. On 2026(b)(6), non-osseointegration was verified. Patient presented with bone type III and inadequate bone quality/quantity. The device was forwarded to the manufacturer. At the event the patient experienced: Pain and Mobility. No further patient complications were reported.

    Patient problems: Fibrosis; Pain

    MAUDE report 50088582 ↗
  • InjuryJul 27, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2025 in the patient's mouth. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50043558 ↗
  • InjuryJul 27, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2026 in FDI 47. On (B)(6) 2026, non-osseointegration was verified. Patient presented with bone type III. No product was returned to the manufacturer. At the event the patient experienced: Peri-implantitis and Pain. No further patient complications were reported.

    Patient problems: Pain; Unspecified Infection

    MAUDE report 50041504 ↗

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page